Latanoprost E Timololo Eg (Latanoprost, Timolol)

Latanoprost, a prostaglandin analog, binds to FP receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. Timolol, a non‑selective beta blocker, reduces aqueous production by blocking beta‑adrenergic receptors. Together they achieve a greater pressure‑lowering effect.

The dosing regimen is determined by the prescribing clinician based on the patient’s condition and response. Typically, one drop is instilled in the affected eye(s) once daily, but the exact schedule should follow the prescriber’s instructions.

Safety data in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent prostaglandin analogs or beta blockers, the combination offers a synergistic pressure‑lowering effect, often achieving target intra‑ocular pressure with fewer drops. This can improve adherence but may increase the spectrum of ocular side effects.

Store the eye drops at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from light and moisture, and discard any solution that appears discolored or contaminated.

The medication is applied as an ophthalmic solution. Tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac without touching the bottle tip to the eye or lashes. Close the eye gently for a few seconds.

Serious adverse events include significant iris pigmentation changes, corneal edema, severe allergic reactions, and systemic beta‑blocker effects such as bradycardia, hypotension or bronchospasm. Patients should seek immediate medical attention if they experience these symptoms.

Contraindications include patients with known hypersensitivity to either component, those with severe asthma or chronic obstructive pulmonary disease, individuals with sinus bradycardia or advanced heart block, and patients with active ocular infections.